| Christine Marie Vincent, LISW | |
|
757 W Benton St, Iowa City, IA 52246-5953 | |
| (319) 339-4757 | |
| Not Available |
| Full Name | Christine Marie Vincent |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 757 W Benton St, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013014703 | NPI | - | NPPES |
| 39249 | Other | IA | BCBS PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 03057 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Marie Vincent, LISW 369 E College St, Iowa City, IA 52240-1690 Ph: (319) 339-4757 | Christine Marie Vincent, LISW 757 W Benton St, Iowa City, IA 52246-5953 Ph: (319) 339-4757 |
News Archive
Leonardo Biosystems, Inc., an emerging drug delivery company, announced today that it has received the second half of a $2.5 million award from the Texas Emerging Technology Fund (TETF). The initial investment tranche was received in April 2010.
Patients with stage I and II Hodgkin's Disease who receive radiation therapy (RT) have a higher 10-year survival rate - 84 percent compared to 76 percent - than those who do not, according to a study presented by researchers at Icahn School of Medicine at Mount Sinai at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting today.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued to the Company patent No. 4,934,432, entitled "Quinazoline Derivatives and Therapeutic Use Thereof."
Obesity is a risk factor for a number of cancer types and can influence cancer treatment outcomes. In 2014, cancer types associated with being overweight or obese represented about 40 percent of all cancers diagnosed in the United States.
Researchers have successfully reduced the symptoms and slowed the progression of Huntington's disease in mice using healthy human brain cells. The findings, which were published today in the journal Nature Communications, could ultimately point to a new method to treat the disease.
› Verified 8 days ago
Christopher M Loeckle, LISW Counselor Medicare: Not Enrolled in Medicare Practice Location: 221 E College St Ste 211, Iowa City, IA 52240 Phone: 319-541-5859 | |
Vicki Lynn Osland, LMSW, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, C124 Gh, Iowa City, IA 52242 Phone: 319-356-8935 Fax: 319-384-9362 | |
Dr. M Kay Colangelo, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 123 N Linn St, Suite 2-d, Iowa City, IA 52245 Phone: 319-337-9461 | |
Mark Biangmano, T-LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 332 S Linn St Ste 40, Iowa City, IA 52240 Phone: 319-894-5069 | |
Bria Sarah Kates, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 509 Kirkwood Ave, Iowa City, IA 52240 Phone: 319-519-2147 | |
Mrs. Amanda Austa Goodrich, M.A., LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 123 N Linn St, Suite 2a, Iowa City, IA 52245 Phone: 319-337-3357 Fax: 319-337-2758 |